Article

The Combined Assessment of CTC and ESR1 Status in Liquid Biopsy Samples Enhances the Clinical Value of Liquid Biopsy in Metastatic Breast Cancer

2025-01-30

Abstract excerpt

Monitoring of metastatic breast cancer (mBC) is an important issue in the clinical management of patients. Liquid biopsy has become a non-invasive method for detecting and monitoring cancer in body fluids. The presence of circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) in peripheral blood indicates poor prognosis and may contribute to early detection of progression, but is still not routine clinica...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d330662f-2467-5bf3-87c7-9d49a617ac34
DOI: 10.20944/preprints202501.2225.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Combined Assessment of CTC and ESR1 Status in Liquid Biopsy Samples Enhances the Clinical Value of Liquid Biopsy in Metastatic Breast CancerDOI 10.20944/preprints202501.2225.v1Read

Complementary information provided by simultaneous sequencing of CTC, cfDNA and metastatic tissue in endocrine-resistant metastatic breast cancerSemantic proximity Read

Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients.Semantic proximity Read

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patientsSemantic proximity Read

Multimodal Targeted Deep Sequencing of Circulating Tumor Cells and Matched Cell-Free DNA Provides a More Comprehensive Tool to Identify Therapeutic Targets in Metastatic Breast Cancer PatientsSemantic proximity Read

[Clinical relevance of ESR1 circulating mutations detection in hormone receptor positive metastatic breast cancer].Semantic proximity Read

Circulating tumor DNA in breast cancer: a biomarker for patient selection.Semantic proximity Read

Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer Patients.Semantic proximity Read

Untitled literature recordSemantic proximity Read

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients.Semantic proximity Read

Liquid biopsy in early breast cancer. A preliminary reportSemantic proximity Read

Circulating Tumor DNA in Early and Metastatic Breast Cance—Current Role and What Is Coming NextSemantic proximity Read

Development of sensitive and robust multiplex digital PCR assays for the detection of ESR1 mutations in the plasma of metastatic breast cancer patients.Semantic proximity Read